Skip to main content
Top
Published in: International Ophthalmology 1/2018

Open Access 01-02-2018 | Original Paper

Changes in choroidal thickness in patients with diabetic retinopathy

Authors: Zaigen Ohara, Hitoshi Tabuchi, Shunsuke Nakakura, Yuki Yoshizumi, Hitomi Sumino, Yukiko Maeda, Yoshiaki Kiuchi

Published in: International Ophthalmology | Issue 1/2018

Login to get access

Abstract

Purpose

To investigate the changes in choroidal thickness (ChT) following panretinal photocoagulation (PRP) for diabetic retinopathy (DR) and compare ChT in relation to DR severity.

Methods

Thirty-two eyes [19 eyes with proliferative DR (PDR) and 13 eyes with severe nonproliferative DR (NPDR)] for which PRP was necessary were analyzed. ChT was measured before PRP and at 1, 3, and 6 months after PRP using the swept-source optical coherence tomography. ChT of the 61 eyes matched with the PDR patients for the mean age and axial length was also measured and statistically compared in relation to severity.

Results

The central field ChT before PRP treatment was 268.6 ± 104.5 µm (mean ± standard deviation) and was significantly decreased at 1, 3, and 6 months after PRP (254.5 ± 105.3, 254.2 ± 108.2, and 248.1 ± 101.8 µm, respectively, P < 0.0001). The central field ChT of severe NPDR (323.2 ± 61.3 µm) was significantly thicker than that of normal (248.3 ± 70.7 µm) and mild to moderate NPDR (230.0 ± 70.3 µm, P = 0.0455 and 0.0099, respectively). Moreover, the central field ChT of PDR (307.3 ± 84.1 µm) was significantly thicker than of mild to moderate NPDR (P = 0.0169).

Conclusion

ChT significantly decreased after PRP, which continued for at least 6 months after treatment. ChT of severe NPDR and PDR was significantly thicker than that of mild to moderate NPDR. ChT of patients with DR was changed according to the treatment and severity of DR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ruta LM, Magliano DJ, Lemesurier R, Taylor HR, Zimmet PZ, Shaw JE (2013) Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med 30:387–398CrossRefPubMed Ruta LM, Magliano DJ, Lemesurier R, Taylor HR, Zimmet PZ, Shaw JE (2013) Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med 30:387–398CrossRefPubMed
2.
go back to reference The Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 88:583–600CrossRef The Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 88:583–600CrossRef
3.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 98(Suppl 5):766–785 Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 98(Suppl 5):766–785
4.
go back to reference Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S54–S64CrossRefPubMed Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S54–S64CrossRefPubMed
5.
go back to reference Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63(1):225–232CrossRefPubMed Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63(1):225–232CrossRefPubMed
6.
go back to reference Spaide RF, Koizumi H, Pozonni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 46:496–500CrossRef Spaide RF, Koizumi H, Pozonni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 46:496–500CrossRef
7.
go back to reference Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS (2012) Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 32:563–568CrossRefPubMedPubMedCentral Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS (2012) Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 32:563–568CrossRefPubMedPubMedCentral
8.
go back to reference Unsal E, Eltutar K, Zirtiloğlu S, Dinçer N, Ozdoğan Erkul S, Güngel H (2014) Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8:637–642CrossRefPubMedPubMedCentral Unsal E, Eltutar K, Zirtiloğlu S, Dinçer N, Ozdoğan Erkul S, Güngel H (2014) Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8:637–642CrossRefPubMedPubMedCentral
9.
go back to reference Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH (2013) Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type II diabetic patients. Invest Ophthalmol Vis Sci 54:3378–3384CrossRefPubMed Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH (2013) Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type II diabetic patients. Invest Ophthalmol Vis Sci 54:3378–3384CrossRefPubMed
10.
go back to reference Cho GE, Cho HY, Kim YT (2013) Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation. Int J Ophthalmol 6:505–509PubMedPubMedCentral Cho GE, Cho HY, Kim YT (2013) Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation. Int J Ophthalmol 6:505–509PubMedPubMedCentral
11.
go back to reference Zhu Y, Zhang T, Wang K, Xu G, Huang X (2015) Changes in choroidal thickness after panretinal photocoagulation in patients with type 2 diabetes. Retina 35:695–703CrossRefPubMed Zhu Y, Zhang T, Wang K, Xu G, Huang X (2015) Changes in choroidal thickness after panretinal photocoagulation in patients with type 2 diabetes. Retina 35:695–703CrossRefPubMed
12.
go back to reference Lee SH, Kim J, Chung H, Kim HC (2014) Changes of choroidal thickness after treatment for diabetic retinopathy. Curr Eye Res 39:736–744CrossRefPubMed Lee SH, Kim J, Chung H, Kim HC (2014) Changes of choroidal thickness after treatment for diabetic retinopathy. Curr Eye Res 39:736–744CrossRefPubMed
13.
go back to reference Zhang Z, Meng X, Wu Z, Zou W, Zhang J, Zhu D et al (2015) Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 2-week longitudinal study. Invest Ophthalmol Vis Sci 56:2631–2638CrossRefPubMed Zhang Z, Meng X, Wu Z, Zou W, Zhang J, Zhu D et al (2015) Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 2-week longitudinal study. Invest Ophthalmol Vis Sci 56:2631–2638CrossRefPubMed
14.
go back to reference Nagasawa T, Mitamura Y, Katome T, Shinomiya K, Naito T, Nagasato D et al (2013) Macular choroidal thickness and volume in healthy pediatric individuals measured by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci 54:7068–7074CrossRefPubMed Nagasawa T, Mitamura Y, Katome T, Shinomiya K, Naito T, Nagasato D et al (2013) Macular choroidal thickness and volume in healthy pediatric individuals measured by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci 54:7068–7074CrossRefPubMed
15.
go back to reference Diabetic Retinopathy Clinical Research Network, Krzystolik MG, Strauber SF, Aiello LP, Beck SF, Berger BB et al (2007) Reproducibility of macular thickness and volume using zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 114:1520–1525CrossRefPubMedCentral Diabetic Retinopathy Clinical Research Network, Krzystolik MG, Strauber SF, Aiello LP, Beck SF, Berger BB et al (2007) Reproducibility of macular thickness and volume using zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 114:1520–1525CrossRefPubMedCentral
16.
go back to reference Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, Global Diabetic Retinopathy Project Group et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682CrossRefPubMed Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, Global Diabetic Retinopathy Project Group et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682CrossRefPubMed
17.
go back to reference The Early Treatment Diabetic Retinopathy Study Research Group (1987) Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 3. Int Ophthalmol Clin 27:254–264CrossRef The Early Treatment Diabetic Retinopathy Study Research Group (1987) Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 3. Int Ophthalmol Clin 27:254–264CrossRef
18.
go back to reference Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S (2004) Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 24:507–511CrossRefPubMed Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S (2004) Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 24:507–511CrossRefPubMed
19.
go back to reference Mendivil A, Cuartero V (1996) Ocular blood flow velocities in patients with proliferative diabetic retinopathy after scatter photocoagulation. Two years of follow-up. Retina 16:222–227CrossRefPubMed Mendivil A, Cuartero V (1996) Ocular blood flow velocities in patients with proliferative diabetic retinopathy after scatter photocoagulation. Two years of follow-up. Retina 16:222–227CrossRefPubMed
20.
go back to reference Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N et al (2010) In vivo laser-tissue interactions and healing responses from 20 vs 100-millisecond pulse Pascal photocoagulation burns. Arch Ophthalmol 128:448–455CrossRefPubMed Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N et al (2010) In vivo laser-tissue interactions and healing responses from 20 vs 100-millisecond pulse Pascal photocoagulation burns. Arch Ophthalmol 128:448–455CrossRefPubMed
21.
go back to reference Paulus YM, Kaur K, Egbert PR, Blumenkranz MS, Moshfeghi DM (2013) Human histopathology of PASCAL laser burns. Eye (Lond) 27:995–996CrossRef Paulus YM, Kaur K, Egbert PR, Blumenkranz MS, Moshfeghi DM (2013) Human histopathology of PASCAL laser burns. Eye (Lond) 27:995–996CrossRef
22.
go back to reference Ikuno Y, Kawaguchi K, Nouchi T (2010) Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci 51:2173–2176CrossRefPubMed Ikuno Y, Kawaguchi K, Nouchi T (2010) Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci 51:2173–2176CrossRefPubMed
23.
go back to reference Michalewski J, Michalewska Z, Nawrocka Z (2014) Correlation of choroidal thickness and volume measurements with axial length and age using swept source optical coherence tomography and optical low-coherence reflectometry. BioMed Res Int 2014:639160CrossRefPubMedPubMedCentral Michalewski J, Michalewska Z, Nawrocka Z (2014) Correlation of choroidal thickness and volume measurements with axial length and age using swept source optical coherence tomography and optical low-coherence reflectometry. BioMed Res Int 2014:639160CrossRefPubMedPubMedCentral
24.
go back to reference Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jmpel HD, Shah ST et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jmpel HD, Shah ST et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed
25.
go back to reference Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargavec S, Vinores MA et al (1997) Upregulation of vascular endothelial growth factor in ischemic and nonischemic human and experimental retinal disease. Histol Histopathol 12:99–109PubMed Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargavec S, Vinores MA et al (1997) Upregulation of vascular endothelial growth factor in ischemic and nonischemic human and experimental retinal disease. Histol Histopathol 12:99–109PubMed
26.
go back to reference Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450CrossRefPubMed Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450CrossRefPubMed
27.
go back to reference Lains I, Figueira J, Santos AR, Baltar A, Costa M, Nunes S et al (2014) Choroidal thickness in diabetic retinopathy: the influence of antiangiogenic therapy. Retina 34:1199–1207CrossRefPubMed Lains I, Figueira J, Santos AR, Baltar A, Costa M, Nunes S et al (2014) Choroidal thickness in diabetic retinopathy: the influence of antiangiogenic therapy. Retina 34:1199–1207CrossRefPubMed
28.
go back to reference Sonoda S, Sakamoto T, Yamashita T, Otsuka H, Shirasawa M, Kakiuchi N et al (2014) Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 55:3979–3985CrossRefPubMed Sonoda S, Sakamoto T, Yamashita T, Otsuka H, Shirasawa M, Kakiuchi N et al (2014) Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 55:3979–3985CrossRefPubMed
Metadata
Title
Changes in choroidal thickness in patients with diabetic retinopathy
Authors
Zaigen Ohara
Hitoshi Tabuchi
Shunsuke Nakakura
Yuki Yoshizumi
Hitomi Sumino
Yukiko Maeda
Yoshiaki Kiuchi
Publication date
01-02-2018
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 1/2018
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0459-9

Other articles of this Issue 1/2018

International Ophthalmology 1/2018 Go to the issue